Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Impact Biomedical Inc. (IBO) had Return on Investments of -76.31% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$0.03M |
|
$-11.84M |
|
$0.42M |
|
$-0.39M |
|
$4.31M |
|
$-4.28M |
|
$-10.17M |
|
$-14.45M |
|
$-14.45M |
|
$-11.87M |
|
$-11.87M |
|
$-11.87M |
|
$-11.87M |
|
$-4.28M |
|
$-3.14M |
|
31.55M |
|
31.55M |
|
$-0.38 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$0.41M |
|
-- |
|
$16.99M |
|
$17.41M |
|
$1.16M |
|
-- |
|
$0.69M |
|
$1.85M |
|
$15.55M |
|
$-1.44M |
|
$15.55M |
|
104.62M |
|
| Cash Flow Statement Financials | |
$-1.89M |
|
$0.00M |
|
$-0.11M |
|
$2.00M |
|
$0.00M |
|
$-2.00M |
|
$0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.35 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-1225.00% |
|
-13381.25% |
|
-13381.25% |
|
-9803.12% |
|
-45156.25% |
|
-36993.75% |
|
$-1.89M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
6.73 |
|
6.40 |
|
57.03 |
|
-76.31% |
|
824.88% |
|
-68.20% |
|
|
Return on Investments |
-76.31% |
$0.15 |
|
$-0.06 |
|
$-0.06 |
|